Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
An Open Label, Pilot Study Testing the Safety and Efficacy of Inhaled Treprostinil (Tyvaso®)
in the Treatment of Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary
Disease (COPD)